AVLAYAH 150 mg/5mL
tividenofusp alfa-eknm · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Denali Therapeutics Inc.
AVLAYAH is a injection, powder, lyophilized, for solution containing tividenofusp alfa-eknm at 150 mg/5mL, taken intravenous. Manufactured by Denali Therapeutics Inc..
Key Facts
- Brand Name
- AVLAYAH
- Generic Name
- tividenofusp alfa-eknm
- NDC Code (Product)
84976-001- Manufacturer
- Denali Therapeutics Inc.
- Strength
- 150 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761485
- Marketing Start
- 04/06/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is AVLAYAH used for?
AVLAYAH contains tividenofusp alfa-eknm. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is AVLAYAH a controlled substance?
AVLAYAH is not classified as a controlled substance by the DEA.
What is the generic name for AVLAYAH?
The generic name for AVLAYAH is tividenofusp alfa-eknm. There are no other listed brand versions of tividenofusp alfa-eknm.
What is the NDC code for AVLAYAH 150 mg/5mL?
The NDC (National Drug Code) for AVLAYAH 150 mg/5mL is 84976-001, listed by Denali Therapeutics Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)